Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP)Register to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 36.5 | 5.6 | 4.5 | 9.3 | 10.3 | |
+/-Cat | 10.5 | 14.7 | 12.4 | 10.6 | 7.9 | |
+/-B’mrk | 3.6 | 5.3 | 2.1 | 2.0 | -7.4 | |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
NAV 06/09/2024 | GBP 36.96 | |
Day Change | -1.07% | |
Morningstar Category™ | Sector Equity Biotechnology | |
IA (formerly IMA) Sector | Specialist | |
ISIN | IE00B42P0H75 | |
Fund Size (Mil) 05/09/2024 | USD 1930.78 | |
Share Class Size (Mil) 05/09/2024 | USD 1160.90 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 30/06/2024 | 1.12% |
Investment Objective: Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP) |
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Pinniger 31/10/2013 | ||
Gareth Powell 31/10/2013 | ||
Inception Date 31/10/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NASDAQ Biotechnology NR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP) | 31/07/2024 |
|
|
Top 5 Holdings | Sector | % |
argenx SE | Healthcare | 6.62 |
Amgen Inc | Healthcare | 6.05 |
Zealand Pharma A/S | Healthcare | 5.78 |
Blueprint Medicines Corp | Healthcare | 4.64 |
Vertex Pharmaceuticals Inc | Healthcare | 4.51 |
Increase Decrease New since last portfolio | ||
Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP) |